64 related articles for article (PubMed ID: 10444282)
1. Efficient adenoviral vector transduction and expression of functional human factor VIII in cultured primary human hepatocytes.
Andrews JL; Weaver L; Kaleko M; Connelly S
Haemophilia; 1999 May; 5(3):160-8. PubMed ID: 10444282
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing therapeutic efficacy and the host immune response to helper-dependent adenoviral gene therapy in hemophilia A mice.
Brown BD; Shi CX; Rawle FE; Tinlin S; McKinven A; Hough C; Graham FL; Lillicrap D
J Thromb Haemost; 2004 Jan; 2(1):111-8. PubMed ID: 14717974
[TBL] [Abstract][Full Text] [Related]
3. Helper-dependent adenoviral gene therapy mediates long-term correction of the clotting defect in the canine hemophilia A model.
McCORMACK WM; Seiler MP; Bertin TK; Ubhayakar K; Palmer DJ; Ng P; Nichols TC; Lee B
J Thromb Haemost; 2006 Jun; 4(6):1218-1225. PubMed ID: 16706963
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for the hemophilias.
VandenDriessche T; Collen D; Chuah MK
J Thromb Haemost; 2003 Jul; 1(7):1550-8. PubMed ID: 12871290
[TBL] [Abstract][Full Text] [Related]
5. A single adeno-associated virus (AAV)-murine factor VIII vector partially corrects the hemophilia A phenotype.
Sarkar R; Xiao W; Kazazian HH
J Thromb Haemost; 2003 Feb; 1(2):220-6. PubMed ID: 12871492
[TBL] [Abstract][Full Text] [Related]
6. Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII.
Chen H; Shi M; Gilam A; Zheng Q; Zhang Y; Afrikanova I; Li J; Gluzman Z; Jiang R; Kong LJ; Chen-Tsai RY
Sci Rep; 2019 Nov; 9(1):16838. PubMed ID: 31727959
[TBL] [Abstract][Full Text] [Related]
7. Expression and characterization of a codon-optimized blood coagulation factor VIII.
Shestopal SA; Hao JJ; Karnaukhova E; Liang Y; Ovanesov MV; Lin M; Kurasawa JH; Lee TK; Mcvey JH; Sarafanov AG
J Thromb Haemost; 2017 Apr; 15(4):709-720. PubMed ID: 28109042
[TBL] [Abstract][Full Text] [Related]
8. Cellular stress and coagulation factor production: when more is not necessarily better.
Chen Z; Herzog RW; Kaufman RJ
J Thromb Haemost; 2023 Dec; 21(12):3329-3341. PubMed ID: 37839613
[TBL] [Abstract][Full Text] [Related]
9. Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A mice.
Ramezani A; Zweier-Renn LA; Hawley RG
Thromb Haemost; 2011 Apr; 105(4):676-87. PubMed ID: 21264447
[TBL] [Abstract][Full Text] [Related]
10. Most factor VIII B domain missense mutations are unlikely to be causative mutations for severe hemophilia A: implications for genotyping.
Ogata K; Selvaraj SR; Miao HZ; Pipe SW
J Thromb Haemost; 2011 Jun; 9(6):1183-90. PubMed ID: 21645226
[TBL] [Abstract][Full Text] [Related]
11. Toward gene therapy for hemophilia A with novel adenoviral vectors: successes and limitations in canine models.
Arruda VR
J Thromb Haemost; 2006 Jun; 4(6):1215-7. PubMed ID: 16706962
[No Abstract] [Full Text] [Related]
12. A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells.
Nguyen GN; Everett JK; Kafle S; Roche AM; Raymond HE; Leiby J; Wood C; Assenmacher CA; Merricks EP; Long CT; Kazazian HH; Nichols TC; Bushman FD; Sabatino DE
Nat Biotechnol; 2021 Jan; 39(1):47-55. PubMed ID: 33199875
[TBL] [Abstract][Full Text] [Related]
13. Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A.
Shi Q; Wilcox DA; Fahs SA; Fang J; Johnson BD; DU LM; Desai D; Montgomery RR
J Thromb Haemost; 2007 Feb; 5(2):352-61. PubMed ID: 17269937
[TBL] [Abstract][Full Text] [Related]
14. Identification of the Efficient Enhancer Elements in FVIII-Padua for Gene Therapy Study of Hemophilia A.
Xiao R; Chen Y; Hu Z; Tang Q; Wang P; Zhou M; Wu L; Liang D
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612447
[TBL] [Abstract][Full Text] [Related]
15. Intra-articular injection of mesenchymal stem cells expressing coagulation factor ameliorates hemophilic arthropathy in factor VIII-deficient mice.
Kashiwakura Y; Ohmori T; Mimuro J; Yasumoto A; Ishiwata A; Sakata A; Madoiwa S; Inoue M; Hasegawa M; Ozawa K; Sakata Y
J Thromb Haemost; 2012 Sep; 10(9):1802-13. PubMed ID: 22784361
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic effects of platelet factor VIII on megakaryopoiesis: implications for a modified human FVIII for platelet-based gene therapy.
Greene TK; Lyde RB; Bailey SC; Lambert MP; Zhai L; Sabatino DE; Camire RM; Arruda VR; Poncz M
J Thromb Haemost; 2014 Dec; 12(12):2102-12. PubMed ID: 25287191
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of endothelial cells corrects the phenotype in hemophilia A mice.
Kumaran V; Benten D; Follenzi A; Joseph B; Sarkar R; Gupta S
J Thromb Haemost; 2005 Sep; 3(9):2022-31. PubMed ID: 16102109
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the consequences of premature termination codons within factor VIII coding sequences.
David D; Santos IM; Johnson K; Tuddenham EG; McVey JH
J Thromb Haemost; 2003 Jan; 1(1):139-46. PubMed ID: 12871551
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-mediated gene delivery specifically targets liver sinusoidal endothelial cells for sustained FVIII expression in hemophilia A mice.
Lawton SM; Manson MA; Fan MN; Chao TY; Chen CY; Kim P; Campbell C; Cai X; Vander Kooi A; Miao CH
Mol Ther; 2024 Apr; 32(4):969-981. PubMed ID: 38341614
[TBL] [Abstract][Full Text] [Related]
20. Giroctocogene fitelparvovec gene therapy for severe hemophilia A: 104-week analysis of the phase 1/2 Alta study.
Leavitt AD; Konkle BA; Stine KC; Visweshwar N; Harrington TJ; Giermasz A; Arkin S; Fang A; Plonski F; Yver A; Ganne F; Agathon D; Resa MLA; Tseng LJ; Di Russo G; Cockroft BM; Cao L; Rupon J
Blood; 2024 Feb; 143(9):796-806. PubMed ID: 37871576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
